Bebida Beverage Co (BBDA) 0.0001 $BBDA HSBC Private Bank

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bebida Beverage Co (BBDA) 0.0001 $BBDA

HSBC Private Bank Bermuda : Company Profile and SWOT Analysis
M2 - Mon Jan 18, 3:26AM CST
Synopsis

Broad Street Alerts - Bebida Beverage Due Diligence Report: Growing Its Revenue Stream
PR Newswire - Thu Nov 12, 7:21AM CST
Bebida Beverage Co. (OTCBB: BBDA) closed at $.0001 off 9.09% in yesterday's session. Trading volume surged to 13 million shares, far above the daily average of 2.6 million shares.

BeBevCo Donates Event Title Towards Fighting Alzheimer's
Marketwired - Mon Aug 24, 8:30AM CDT
In recognition of the national fight to end Alzheimer's, Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer, marketer of relaxation, energy drinks and shots, announced today that it has donated its title sponsorship for the upcoming KOMA Unwind(R) Modified Madness Series event to a rising charity.

BeBevCo Offers Clarification on Today's Announcement With Stock Swap With ISGP
Marketwired - Tue Jul 14, 7:01AM CDT
Bebida Beverage Company (OTC: BBDA) BeBevCo, a developer, manufacturer, marketer of relaxation, energy drinks and liquid dietary supplements announced today it has entered into an agreement with International Sustainability Group Inc. (OTC: ISGP). The company wanted to clarify that its agreement is that each company will offer restricted stock equal in value to 50k to one another (Stock Swap). This will have each company holding a position in the other which in turn will set the stage for other phases including but not limited to a joint venture to develop Algae infused beverages. Any joint venture will be formed after proper due diligence is completed.

BeBevCo Enters Partnership With International Sustainability Group, Inc. With Investment, Joint Ventures in Leading Algae-Based Supplement Line
Marketwired - Mon Jul 13, 9:00AM CDT
Bebida Beverage Company (OTC: BBDA) BeBevCo, a developer, manufacturer, marketer of relaxation, energy drinks and liquid dietary supplements has entered into an agreement to invest $50,000.00 into International Sustainability Group Inc. (OTC: ISGP). The investment will be made using BBDA restricted legend stock. This is the first step of several joint ventures between the companies that include multiple product development projects using ISGP Algae nutritional products.

Bebida Beverage Company Salutes Long-Term Shareholders as CEO Works to Build Brand, Partnerships and Launch of Direct Response Advertising Platform
Marketwired - Tue Jul 07, 8:20AM CDT
Bebida Beverage Company (OTC: BBDA) BeBevCo, a developer, manufacturer, marketer of relaxation, energy drinks and liquid dietary supplements CEO offers the following shareholder update:

BeBevCo Lands New International Distribution Partner for KOMA Unwind
Marketwired - Fri Jun 12, 8:15AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer, marketer of relaxation, energy drinks and liquid dietary supplements announced today that they have signed a new International distribution agreement and have a pending first order in excess of $300,000.

Bebida Beverage Company Reduces Outstanding Shares by 43,000,000
Marketwired - Tue Jun 09, 8:20AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer, marketer of relaxation, energy drinks and shots announced today the company has recovered and retired 43,000,000 of the company's current issued and outstanding stock.

BeBevCo CEO Participates in Several New Interviews
Marketwired - Wed May 06, 8:45AM CDT
Bebida Beverage Company (OTC: BBDA) (BeBevCo), a developer, manufacturer, marketer of relaxation, energy drinks and shots, announced today that its CEO, Brian Weber, recently participated in several new interviews.

BeBevCo Donates Title Sponsorship to AutismSmilesLLC.org for Upcoming Event
Marketwired - Thu Apr 09, 12:15PM CDT
In recognition of National Autism Awareness Month, Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer, marketer of relaxation and energy drinks and shots announced today that it has donated its title sponsorship for the upcoming KOMA Unwind(R) Modified Madness Series event to a rising charity.

DTC Lifts Bebida Beverage Company "Chill"
PR Newswire - Thu Jan 22, 12:15PM CST
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products announced today that The Depository Trust Company (DTC) has determined to lift the Deposit Chill on the company's stock effective January 21, 2015, and has resumed accepting deposits of Bebida Beverage Company's common stock for depository and book entry transfer services.

BeBevCo Announces Stock Restructuring
PR Newswire - Thu Dec 18, 9:00AM CST
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy drinks and shots announced today that its board has approved and submitted the requisite paperwork to FINRA to effectuate a 100-1 reverse stock split.

BeBevCo Signs Largest License Agreement to Date for KOMA Unwind Relaxation Drink
PR Newswire - Thu Dec 04, 12:30PM CST
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy drinks is pleased to announce it has signed a long term license agreement with Sparkling Drink Systems International (SDS), the Global Beverage Solution Provider.

BeBevCo Adds Harbor Pacific Distribution
PR Newswire - Thu Nov 13, 9:24AM CST
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy drinks announced today that it has signed an exclusive distribution agreement with Harbor Pacific a regional Pepsi distributor to begin distributing the company's flagship product, KOMA Unwind® Liquid Relaxation® (drink) effective immediately.

Bebida Beverage Analyst Brief: Ready to Experience a Relaxing Growth Spurt by Small Cap Street
PR Newswire - Fri Oct 31, 6:00AM CDT
Analyst Brief by Small Cap Street. Bebida Beverage Company (OTCBB: BBDA) develops, manufactures and markets liquid relaxation products including, KOMA Unwind Liquid Relaxation®, KOMA Unwind Sugar-free Liquid Relaxation®, and KOMA Unwind Liquid Relaxation Shots®, as well as POTENCIA Energy, POTENCIA BLAST Energy Shots and Relax 5 Shots.

BeBevCo Strikes Gold With Golden Beverage As Perfect Alignment For KOMA Unwind Relaxation Drink
PR Newswire - Mon Oct 27, 8:55AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products announced today that have added yet another distribution partner for the company's flagship product, KOMA Unwind Liquid Relaxation® (drink) in Golden Beverage LLC.

BeBevCo CEO Presents KOMA Unwind To NW PAC Pepsi
PR Newswire - Tue Oct 21, 8:57AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products announced today that BeBevCo CEO Brian Weber will lay out the business opportunity of distributing the company's flagship product, KOMA Unwind Liquid Relaxation® (drink) to all Pacific Northwest Independent Pepsi Bottlers and distributors.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading